Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial

XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
clinical-trialsefficacyinduced-pluripotent-stem-cellssafetyspinal-cord-injurytransplantation
spinal cord injury, safety, clinical trials, efficacy, induced pluripotent stem cells, human motor neuron progenitor, transplantation, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 853163
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.